Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients – results of a phase II Nordic Lymphoma Group study




results of a phase II Nordic Lymphoma Group study

Holte H, Leppä S, Björkholm M, Fluge Ø, Jyrkkiö S, Delabie J, Sundström C, Karjalainen-Lindsberg ML, Erlanson M, Kolstad A, Fosså A, Østenstad B, Löfvenberg E, Nordström M, Janes R, Pedersen LM, Anderson H, Jerkeman M, Eriksson M

PublisherOxford University Press

2013

Annals of Oncology

24

5

1385

1392

8

0923-7534

1569-8041

DOIhttps://doi.org/10.1093/annonc/mds621




Last updated on 2024-26-11 at 12:49